{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:59:37Z","timestamp":1787165977201,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IDT Biologika GmbH"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2017.09.093","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T07:02:48Z","timestamp":1508137368000},"page":"4750-4757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs"],"prefix":"10.1016","volume":"37","author":[{"given":"Conrad M.","family":"Freuling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Eggerbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Nolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens P.","family":"Teifke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Mettenleiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2017.09.093_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7589\/0090-3558-44.1.71","article-title":"ERA Vaccine-derivied cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989\u20132004","volume":"44","author":"Fehlner-Gardiner","year":"2008","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2017.09.093_b0010","doi-asserted-by":"crossref","unstructured":"Freuling C, Hampson K, Selhorst T, Schr\u00f6der R, Meslin FX, Mettenleiter TC, et al. The elimination of fox rabies from Europe: determinants of success and lessons for the future. Philos Trans R Soc Lond B Biol Sci. 2013;368(1623).","DOI":"10.1098\/rstb.2012.0142"},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.093_b0015","doi-asserted-by":"crossref","first-page":"e0003953","DOI":"10.1371\/journal.pntd.0003953","article-title":"Spatio-temporal use of oral rabies vaccines in fox rabies elimination programmes in Europe","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.09.093_b0020","doi-asserted-by":"crossref","unstructured":"Slate D, Algeo TP, Nelson KM, Chipman RB, Donovan D, Blanton JD, et al. Oral rabies vaccination in North America: opportunities, complexities, and challenges. PLOS Negl Trop Dis 2009;3(12):e549. https:\/\/doi.org\/10.1371\/journal.pntd.0000549. [Epub 2009\/12\/23. PubMed PMID: 20027214; PubMed Central PMCID: PMC2791170].","DOI":"10.1371\/journal.pntd.0000549"},{"key":"10.1016\/j.vaccine.2017.09.093_b0025","doi-asserted-by":"crossref","unstructured":"Fehlner-Gardiner C, Rudd R, Donovan D, Slate D, Kempf L, Badcock J. Comparing ONRAB(R) AND RABORAL V-RG(R) oral rabies vaccine field performance in raccoons and striped skunks, New Brunswick, Canada, and Maine, USA. J Wildl Dis 2012;48(1):157\u201367. https:\/\/doi.org\/10.7589\/0090-3558-48.1.157. [Epub 2012\/01\/17. PubMed PMID: 22247384].","DOI":"10.7589\/0090-3558-48.1.157"},{"key":"10.1016\/j.vaccine.2017.09.093_b0030","doi-asserted-by":"crossref","unstructured":"Rosatte RC, Donovan D, Davies JC, Allan M, Bachmann P, Stevenson B, et al. Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada. J Wildl Dis. 2009;45(2):363\u201374. https:\/\/doi.org\/10.7589\/0090-3558-45.2.363. [Epub 2009\/04\/28. PubMed PMID: 19395746].","DOI":"10.7589\/0090-3558-45.2.363"},{"key":"10.1016\/j.vaccine.2017.09.093_b0035","first-page":"315","article-title":"Ein Feldversuch zur oralen Immunisierung von F\u00fcchsen gegen die Tollwut in der Bundesrepublik Deutschland: Unsch\u00e4dlichkeit, Wirksamkeit und Stabilit\u00e4t der Vakzine SAD B 19","volume":"38","author":"Schneider","year":"1983","journal-title":"Tierarztl Umsch."},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.093_b0040","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0264-410X(92)90351-J","article-title":"Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison","volume":"10","author":"Artois","year":"1992","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.09.093_b0045","first-page":"103","article-title":"Innocuity tests with SAD B19 in Turkish non-target species","volume":"9","author":"G\u00fczel","year":"1998","journal-title":"J ETLIK Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.09.093_b0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0950268899002666","article-title":"An update on safety studies of SAD B 19 rabies virus vaccine in target and non-target species","volume":"123","author":"Vos","year":"1999","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2017.09.093_b0055","first-page":"1081","article-title":"Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria","volume":"154","author":"M\u00fcller","year":"2009","journal-title":"Adv Virol"},{"key":"10.1016\/j.vaccine.2017.09.093_b0060","doi-asserted-by":"crossref","unstructured":"Hostnik P, Picard-Meyer E, Rihtaric D, Toplak I, Cliquet F. Vaccine-induced Rabies in a Red Fox (Vulpes vulpes): Isolation of Vaccine Virus in Brain Tissue and Salivary Glands. J Wildl Dis 2014. https:\/\/doi.org\/10.7589\/2013-07-183. [Epub 2014\/02\/04. PubMed PMID: 24484500].","DOI":"10.7589\/2013-07-183"},{"issue":"41","key":"10.1016\/j.vaccine.2017.09.093_b0065","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1016\/j.vaccine.2016.08.013","article-title":"Vaccine-induced rabies case in a cow (Bos taurus): molecular characterisation of vaccine strain in brain tissue","volume":"34","author":"Vuta","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.09.093_b0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2013.07.012","article-title":"Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination","volume":"100","author":"Cliquet","year":"2013","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.vaccine.2017.09.093_b0075","doi-asserted-by":"crossref","first-page":"e0141537","DOI":"10.1371\/journal.pone.0141537","article-title":"In-Depth characterization of live vaccines used in Europe for oral rabies vaccination of wildlife","volume":"10","author":"Cliquet","year":"2015","journal-title":"PLoS ONE"},{"issue":"43","key":"10.1016\/j.vaccine.2017.09.093_b0080","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1016\/j.vaccine.2015.08.091","article-title":"High definition viral vaccine strain identity and stability testing using full-genome population data - the next generation of vaccine quality control","volume":"33","author":"H\u00f6per","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.093_b0085","first-page":"1","article-title":"Expert consultation on rabies, second report","volume":"982","author":"World Health Organisation","year":"2013","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.vaccine.2017.09.093_b0090","first-page":"1","article-title":"Expert consultation on rabies, first report","volume":"931","author":"World Health Organisation","year":"2005","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"4","key":"10.1016\/j.vaccine.2017.09.093_b0095","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0264-410X(94)90095-7","article-title":"Vaccination against rabies. construction and characterization of SAG2, a double avirulent derivative a SAD Bern","volume":"12","author":"Lafay","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.09.093_b0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13567-014-0077-8","article-title":"Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review","volume":"45","author":"Mahl","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2017.09.093_b0105","unstructured":"Schneider L. inventorTollwut-Lebendimpfstoff. Deutschland patent 0210552 B1; 1986."},{"issue":"5990","key":"10.1016\/j.vaccine.2017.09.093_b0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/312163a0","article-title":"Expression of rabies virus glycoprotein from a recombinant vaccinia virus","volume":"312","author":"Kieny","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.09.093_b0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/322373a0","article-title":"Oral vaccination of the fox against rabies using a live recombinant vaccinia virus","volume":"332","author":"Blancou","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.09.093_b0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/infdis\/161.1.27","article-title":"A recombinant human adenovirus vaccine against rabies","volume":"161","author":"Prevec","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.093_b0125","doi-asserted-by":"crossref","unstructured":"Xiang ZQ, Yang Y, Wilson JM, Ertl HC. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 1996;219(1):220\u20137. https:\/\/doi.org\/10.1006\/viro.1996.0239. [Epub 1996\/05\/01. PubMed PMID: 8623532].","DOI":"10.1006\/viro.1996.0239"},{"issue":"29","key":"10.1016\/j.vaccine.2017.09.093_b0130","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.vaccine.2014.04.029","article-title":"Oral vaccination and protection of striped skunks (Mephitis mephitis) against rabies using ONRAB(R)","volume":"32","author":"Brown","year":"2014","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.09.093_b0135","doi-asserted-by":"crossref","unstructured":"Brown LJ, Rosatte RC, Fehlner-Gardiner C, Bachmann P, Ellison JA, Jackson FR, et al. Oral vaccination and protection of red foxes (Vulpes vulpes) against rabies using ONRAB((R)), an adenovirus-rabies recombinant vaccine. Vaccine. 2014;32(8):984\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.015. [Epub 2014\/01\/01. PubMed PMID: 24374501].","DOI":"10.1016\/j.vaccine.2013.12.015"},{"key":"10.1016\/j.vaccine.2017.09.093_b0140","doi-asserted-by":"crossref","unstructured":"Slate D, Chipman RB, Algeo TP, Mills SA, Nelson KM, Croson CK, et al. Safety and immunogenicity of ontario rabies vaccine bait (onrab) in the first us field trial in raccoons (Procyon lotor). J Wildl Dis 2014;50(3):582\u201395. https:\/\/doi.org\/10.7589\/2013-08-207. [Epub 2014\/05\/09. PubMed PMID: 24807178].","DOI":"10.7589\/2013-08-207"},{"key":"10.1016\/j.vaccine.2017.09.093_b0145","first-page":"293","article-title":"\u00c9limination de la rage en Belgique par la vaccination du renard roux (Vulpes vulpes)","volume":"145","author":"Brochier","year":"2001","journal-title":"Ann Med Vet"},{"key":"10.1016\/j.vaccine.2017.09.093_b0150","first-page":"119","article-title":"Means used for terrestrial rabies elimination in France and policy for rabies surveillance in case of re-emergence","volume":"125","author":"Cliquet","year":"2006","journal-title":"Dev Biol (Basel)"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.093_b0155","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2460\/ajvr.1989.50.06.836","article-title":"Oral vaccination of dogs fed canine adenovirus in baits","volume":"50","author":"Baer","year":"1989","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.093_b0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2007.11.029","article-title":"Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies","volume":"26","author":"Zhang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.093_b0165","doi-asserted-by":"crossref","unstructured":"Wright N, Jackson FR, Niezgoda M, Ellison JA, Rupprecht CE, Nel LH. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines. Vaccine 2013 Aug 28(31(38):4177\u201382. https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.089. [Epub 2013 Jul 16].","DOI":"10.1016\/j.vaccine.2013.06.089"},{"issue":"21","key":"10.1016\/j.vaccine.2017.09.093_b0170","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1016\/j.vaccine.2007.02.084","article-title":"Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies","volume":"25","author":"Weyer","year":"2007","journal-title":"Vaccine"},{"issue":"6\u20137","key":"10.1016\/j.vaccine.2017.09.093_b0175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1863-2378.2008.01215.x","article-title":"Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife","volume":"56","author":"Faber","year":"2009","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.vaccine.2017.09.093_b0180","first-page":"461","article-title":"Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs","volume":"131","author":"Bankovskiy","year":"2008","journal-title":"Dev Biol (Basel)"},{"issue":"18","key":"10.1016\/j.vaccine.2017.09.093_b0185","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J"},{"issue":"22","key":"10.1016\/j.vaccine.2017.09.093_b0190","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.093_b0195","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/JVI.06699-11","article-title":"Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues","volume":"86","author":"Li","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.093_b0200","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/JVI.02589-12","article-title":"Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies","volume":"87","author":"Schutsky","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.09.093_b0205","doi-asserted-by":"crossref","unstructured":"Rieder M, Brzozka K, Pfaller CK, Cox JH, Stitz L, Conzelmann KK. Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J Virol 2011;85(2):842\u201352. https:\/\/doi.org\/10.1128\/JVI.01427-10. [Epub 2010\/11\/19. PubMed PMID: 21084487; PubMed Central PMCID: PMC3020028].","DOI":"10.1128\/JVI.01427-10"},{"issue":"23","key":"10.1016\/j.vaccine.2017.09.093_b0210","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1128\/JVI.75.23.11496-11502.2001","article-title":"Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein","volume":"75","author":"Mebatsion","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.09.093_b0215","first-page":"1","article-title":"Development of an oral rabies vaccine with improved safety and efficacy to control canine rabies in ownerless and stray dogs","author":"Mebatsion","year":"2001","journal-title":"Virol Res Dev"},{"issue":"10","key":"10.1016\/j.vaccine.2017.09.093_b0220","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1099\/0022-1317-80-10-2545","article-title":"Ecology and evolution of rabies virus in Europe","volume":"80","author":"Bourhy","year":"1999","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.09.093_b0225","doi-asserted-by":"crossref","first-page":"617","DOI":"10.7589\/0090-3558-40.4.617","article-title":"Molecular epidemiology of terrestrial rabies in the former Soviet Union","volume":"40","author":"Kuzmin","year":"2004","journal-title":"J Wildl Dis"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2017.09.093_b0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virusres.2010.02.008","article-title":"Molecular epidemiology of rabies virus in Romania provides evidence for a high degree of heterogeneity and virus diversity","volume":"150","author":"Turcitu","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.09.093_b0235","doi-asserted-by":"crossref","unstructured":"Picard-Meyer E, Robardet E, Moroz D, Trotsenko Z, Drozhzhe Z, Biarnais M, et al. Molecular epidemiology of rabies in Ukraine. Arch Virol. 2012;157(9):1689\u201398. https:\/\/doi.org\/10.1007\/s00705-012-1351-6. [Epub 2012\/06\/05. PubMed PMID: 22661376].","DOI":"10.1007\/s00705-012-1351-6"},{"issue":"24","key":"10.1016\/j.vaccine.2017.09.093_b0240","doi-asserted-by":"crossref","first-page":"15405","DOI":"10.1128\/JVI.79.24.15405-15416.2005","article-title":"Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice","volume":"79","author":"Faber","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.09.093_b0245","first-page":"227","article-title":"The Method of \u201cRight and Wrong Cases\u201d (Constant Stimuli) without Gauss\u2019s Formula","volume":"2","author":"Spearman","year":"1908","journal-title":"Br J Psychol"},{"key":"10.1016\/j.vaccine.2017.09.093_b0250","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Arch Exp Path Pharmakol."},{"issue":"1","key":"10.1016\/j.vaccine.2017.09.093_b0255","first-page":"37","article-title":"Clinical endpoints during rabies vaccine control tests","volume":"18","author":"Hartinger","year":"2000","journal-title":"Altex"},{"key":"10.1016\/j.vaccine.2017.09.093_b0260","series-title":"Laboratory techniques in rabies","first-page":"88","article-title":"The fluorescence antibody test","author":"Dean","year":"1996"},{"key":"10.1016\/j.vaccine.2017.09.093_b0265","series-title":"Laboratory techniques in rabies","first-page":"93","article-title":"Virus isolation in neuroblastoma cell culture","author":"Webster","year":"1996"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.093_b0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/jcm.3.2.96-101.1976","article-title":"Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine","volume":"3","author":"Cox","year":"1976","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.09.093_b0275","first-page":"195","article-title":"Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2","volume":"125","author":"M\u00fcller","year":"2006","journal-title":"Dev Biol (Basel)"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.093_b0280","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jviromet.2012.11.022","article-title":"Evaluation of an ELISA to detect rabies antibodies in orally vaccinated foxes and raccoon dogs sampled in the field","volume":"187","author":"Wasniewski","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2017.09.093_b0285","doi-asserted-by":"crossref","unstructured":"Wasniewski M, Cliquet F. Evaluation of ELISA for detection of rabies antibodies in domestic carnivores. J Virol Methods 2012;179(1):166\u201375. https:\/\/doi.org\/10.1016\/j.jviromet.2011.10.019. [Epub 2011\/11\/15. PubMed PMID: 22080853].","DOI":"10.1016\/j.jviromet.2011.10.019"},{"key":"10.1016\/j.vaccine.2017.09.093_b0290","doi-asserted-by":"crossref","unstructured":"Cliquet F, Picard-Meyer E, Robardet E. Rabies in Europe: what are the risks? Expert review of anti-infective therapy 2014;12(8):905\u20138. https:\/\/doi.org\/10.1586\/14787210.2014.921570. [Epub 2014\/05\/23. PubMed PMID: 24847903].","DOI":"10.1586\/14787210.2014.921570"},{"key":"10.1016\/j.vaccine.2017.09.093_b0295","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tvjl.2014.10.026","article-title":"Terrestrial rabies control in the European Union: Historical achievements and challenges ahead","volume":"203","author":"M\u00fcller","year":"2014","journal-title":"Vet J"},{"issue":"1","key":"10.1016\/j.vaccine.2017.09.093_b0300","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7589\/0090-3558-37.1.119","article-title":"Elimination of rabies from red foxes in eastern Ontario","volume":"37","author":"MacInnes","year":"2001","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2017.09.093_b0305","doi-asserted-by":"crossref","unstructured":"Rosatte RC, Power MJ, Donovan D, Davies JC, Allan M, Bachmann P, et al. Elimination of arctic variant rabies in red foxes, metropolitan Toronto. Emerg Infect Dis 2007;13(1):25\u20137. https:\/\/doi.org\/10.3201\/eid1301.060622. [Epub 2007\/03\/21. PubMed PMID: 17370512; PubMed Central PMCID: PMC2725809].","DOI":"10.3201\/eid1301.060622"},{"key":"10.1016\/j.vaccine.2017.09.093_b0310","first-page":"195","article-title":"Innocuite et efficacite d'un vaccin antirabique recombinant des virus de la vaccine et de la rage administre par voie orale au renard, au chiery et au chat","volume":"20","author":"Blancou","year":"1989","journal-title":"Ann Rech Vet."},{"issue":"7","key":"10.1016\/j.vaccine.2017.09.093_b0315","first-page":"165","article-title":"Efficacy of a baiting system for vaccinating foxes against rabies with vaccinia-rabies recombinant virus","volume":"127","author":"Brochier","year":"1990","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2017.09.093_b0320","first-page":"169","article-title":"The safety and efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies virus vaccine","volume":"44","author":"Black","year":"1980","journal-title":"Can J Comp Med."},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.093_b0325","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1439-0450.2001.00440.x","article-title":"Immunogenicity and efficacy of the oral rabies vaccine SAD B19 in foxes","volume":"48","author":"Neubert","year":"2001","journal-title":"J Vet Med Ser B-Infect Dis Vet Pub Health"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.093_b0330","first-page":"285","article-title":"Comparative immunogenicity and efficacy studies with oral rabies virus vaccine SAD P5\/88 in raccoon dogs and red foxes","volume":"49","author":"Schuster","year":"2001","journal-title":"Acta Vet Hung"},{"key":"10.1016\/j.vaccine.2017.09.093_b0335","first-page":"257","article-title":"Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog and raccoon dog","volume":"131","author":"Cliquet","year":"2008","journal-title":"Dev Biol (Basel)"},{"issue":"20","key":"10.1016\/j.vaccine.2017.09.093_b0340","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1016\/j.vaccine.2006.02.057","article-title":"Safety and efficacy of the oral rabies vaccine SAG2 in raccoon dogs","volume":"24","author":"Cliquet","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.093_b0345","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7589\/0090-3558-40.2.328","article-title":"Oral vaccination of captive arctic foxes with lyophilized SAG2 rabies vaccine","volume":"40","author":"Follmann","year":"2004","journal-title":"J Wildl Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.093_b0350","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/vr.140.3.57","article-title":"Effectiveness of SAG1 oral vaccine for the long-term protection of red foxes (Vulpes vulpes) against rabies","volume":"140","author":"Artois","year":"1997","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2017.09.093_b0355","doi-asserted-by":"crossref","unstructured":"Faber M, Pulmanausahakul R, Hodawadekar SS, Spitsin S, McGettigan JP, Schnell MJ, et al. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J Virol 2002;76(7):3374\u201381 [PubMed PMID: 11884563; PubMed Central PMCID: PMC136034].","DOI":"10.1128\/JVI.76.7.3374-3381.2002"},{"issue":"42","key":"10.1016\/j.vaccine.2017.09.093_b0360","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1016\/j.vaccine.2007.08.004","article-title":"Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines","volume":"25","author":"Blanton","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.09.093_b0365","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2017.09.093_b0370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-1135(93)90083-J","article-title":"Efficacy of 3 oral rabies vaccine-baits in the red fox - a comparison","volume":"38","author":"Artois","year":"1993","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2017.09.093_b0375","doi-asserted-by":"crossref","unstructured":"Irie T, Kawai A. Studies on the different conditions for rabies virus neutralization by monoclonal antibodies #1-46-12 and #7-1-9. J Gen Virol. 2002;83(Pt 12):3045\u201353. https:\/\/doi.org\/10.1099\/0022-1317-83-12-3045. [Epub 2002\/12\/06. PubMed PMID: 12466481].","DOI":"10.1099\/0022-1317-83-12-3045"},{"key":"10.1016\/j.vaccine.2017.09.093_b0380","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1993.1261","article-title":"Mechanisms of rabies virus neutralization","volume":"194","author":"Flamand","year":"1993","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.093_b0385","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-specific antibodies: measuring surrogates of protection against a fatal disease","volume":"4","author":"Moore","year":"2010","journal-title":"PLOS Negl Trop Dis Dis"},{"key":"10.1016\/j.vaccine.2017.09.093_b0390","doi-asserted-by":"crossref","unstructured":"Moore SM, Ricke TA, Davis RD, Briggs DJ. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays. Biologicals 2005;33(4):269\u201376. https:\/\/doi.org\/10.1016\/j.biologicals.2005.06.005 [PubMed PMID: 16168666].","DOI":"10.1016\/j.biologicals.2005.06.005"},{"key":"10.1016\/j.vaccine.2017.09.093_b0395","unstructured":"OIE. Chapter 2.1.17. Rabies (infection with rabies virus) (NB: Version adopted in May 2013). Manual of diagnostic tests and vaccines for terrestrial animals 2017;Section B:1\u201328."},{"key":"10.1016\/j.vaccine.2017.09.093_b0400","series-title":"Viral infection","first-page":"134","article-title":"Rabies virus: epidemiological aspects of virus adaptation to different animal species","author":"Blancou","year":"1986"},{"key":"10.1016\/j.vaccine.2017.09.093_b0405","unstructured":"Wachend\u00f6rfer G, Frost JW. Epidemiology of red fox rabies: a review. In: B\u00f6gel K, Meslin FX, Kaplan M, editors. Wildlife rabies control Kent. Wells Medical Ltd; 1992. p. 19\u201331."},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.093_b0410","doi-asserted-by":"crossref","first-page":"e0004023","DOI":"10.1371\/journal.pntd.0004023","article-title":"Differential host immune responses after infection with wild-type or lab-attenuated rabies viruses in dogs","volume":"9","author":"Gnanadurai","year":"2015","journal-title":"PLOS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2017.09.093_b0415","unstructured":"European Commission. The oral vaccination of foxes against rabies. Report of the Scientific Committee on Animal Health and Animal Welfare Adopted on 23 October 20022002."},{"key":"10.1016\/j.vaccine.2017.09.093_b0420","doi-asserted-by":"crossref","unstructured":"EFSA. Scientific opinion - update on oral vaccination of foxes and raccoon dogs against rabies. EFSA J 2015;13(7):4164. https:\/\/doi.org\/10.2903\/j.efsa.2015.4164.","DOI":"10.2903\/j.efsa.2015.4164"},{"issue":"1","key":"10.1016\/j.vaccine.2017.09.093_b0425","first-page":"39","article-title":"Duration of immunity in foxes vaccinated orally with ERA vaccine in a bait","volume":"61","author":"Lawson","year":"1997","journal-title":"Can J Vet Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731366X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731366X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T10:16:24Z","timestamp":1750932984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1731366X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":85,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X1731366X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.093","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}